KRAS and non-small cell lung carcinoma: On further analysis incorporating TMB analysis, we saw a trend towards lower TMB in HR+ NSCLC but we saw a trend towards higher TMB in females in HR+ NSCLC and that HR+ KRAS mutant females specifically had a significantly higher TMB in comparison to males.